从机制到应用:纳米医学驱动的癌症疗法中的编程细胞死亡途径
Zhan Zhang1,2,3, Yuanzhen Wu1, Yanchen Liu1
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Bioactive materials
|July 18, 2025
概括
工程纳米药物增强了编程细胞死亡 (PCD) 途径,如用于癌症治疗的cuproptosis,pyroptosis和ferroptosis. 这些纳米药物改善了药物输送,并针对多种PCD机制,克服了治疗的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 纳米技术 纳米技术
背景情况:
- 编程细胞死亡 (PCD) 在癌症预防和进展中至关重要.
- 杯性,热性和铁性是PCD关键途径,具有直接的抗瘤作用和免疫增强能力.
- 目前PCD诱导剂面临的挑战包括耐药性,快速新陈代谢和非目标毒性.
研究的目的:
- 审查cuproptosis,pyroptosis和ferroptosis在癌症中的作用和机制.
- 探索纳米药物如何调节这些PCD途径以增强癌症治疗.
- 讨论针对多个PCD机制的基于纳米医学的组合策略.
主要方法:
- 对PCD途径和纳米医学在癌症中的应用现有文献的系统审查.
- 对cuproptosis,pyroptosis和ferroptosis的病理生理学作用,机制和治疗影响的分析.
- 检查纳米医学策略来准和激活PCD路径.
主要成果:
- 纳米药物为PCD诱导剂提供了改善的药理动力学,有针对性的输送和增强的稳定性.
- 工程纳米药物可以同时激活多个PCD路径,并与传统疗法结合.
- 基于纳米医学的方法显示出克服单通道PCD诱导局限性的潜力.
结论:
- 纳米药物对优化基于cuproptosis,pyroptosis和ferroptosis的癌症疗法具有显著的希望.
- 用纳米药物准多个PCD途径可以放大抗瘤效果并提高安全性.
- 需要进一步的研究和临床转化来实现PCD向纳米药物的全部潜力.
相关概念视频
Overview of Cell Death
7.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Apoptosis
12.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K


